These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 37239833)
1. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase. He XY; Dobkin C; Brown WT; Yang SY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833 [TBL] [Abstract][Full Text] [Related]
2. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study. He XY; Dobkin C; Brown WT; Yang SY J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658 [TBL] [Abstract][Full Text] [Related]
3. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease. He XY; Isaacs C; Yang SY J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196 [TBL] [Abstract][Full Text] [Related]
4. Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer's Disease. He XY; Frackowiak J; Dobkin C; Brown WT; Yang SY Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139430 [TBL] [Abstract][Full Text] [Related]
5. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders. Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment. Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370 [TBL] [Abstract][Full Text] [Related]
8. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Yang SY; He XY; Schulz H Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413 [TBL] [Abstract][Full Text] [Related]
9. Hydroxysteroid (17β) dehydrogenase X in human health and disease. Yang SY; He XY; Miller D Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223 [TBL] [Abstract][Full Text] [Related]
10. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation. Benek O; Hroch L; Aitken L; Dolezal R; Guest P; Benkova M; Soukup O; Musil K; Kuca K; Smith TK; Gunn-Moore F; Musilek K Med Chem; 2017 Jan; ():. PubMed ID: 28067167 [TBL] [Abstract][Full Text] [Related]
11. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment. Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457 [No Abstract] [Full Text] [Related]
12. A 5-methylcytosine hotspot responsible for the prevalent HSD17B10 mutation. Yang SY; Dobkin C; He XY; Philipp M; Brown WT Gene; 2013 Feb; 515(2):380-4. PubMed ID: 23266819 [TBL] [Abstract][Full Text] [Related]
13. HSD10 disease: clinical consequences of mutations in the HSD17B10 gene. Zschocke J J Inherit Metab Dis; 2012 Jan; 35(1):81-9. PubMed ID: 22127393 [TBL] [Abstract][Full Text] [Related]
14. Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase. He XY; Yang YZ; Schulz H; Yang SY Biochem J; 2000 Jan; 345 Pt 1(Pt 1):139-43. PubMed ID: 10600649 [TBL] [Abstract][Full Text] [Related]
15. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease. Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248 [TBL] [Abstract][Full Text] [Related]
17. Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts. Deutschmann AJ; Amberger A; Zavadil C; Steinbeisser H; Mayr JA; Feichtinger RG; Oerum S; Yue WW; Zschocke J Hum Mol Genet; 2014 Jul; 23(13):3618-28. PubMed ID: 24549042 [TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene. Su L; Li X; Lin R; Sheng H; Feng Z; Liu L Metab Brain Dis; 2017 Dec; 32(6):2063-2071. PubMed ID: 28875337 [TBL] [Abstract][Full Text] [Related]
19. Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias. Kristofikova Z; Ricny J; Vyhnalek M; Hort J; Laczo J; Sirova J; Klaschka J; Ripova D J Alzheimers Dis; 2015; 48(1):105-14. PubMed ID: 26401932 [TBL] [Abstract][Full Text] [Related]
20. Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism. Yang SY; He XY; Olpin SE; Sutton VR; McMenamin J; Philipp M; Denman RB; Malik M Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14820-4. PubMed ID: 19706438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]